+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-04-25Number of Pages: 78

Cerebrospinal Fluid (CSF) Management Market (Product - CSF Shunts and CSF Drainage Systems) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

Hydrocephalus is defined as an imbalance between the production and absorption of CSF. This increase in CSF may be due to numerous reasons such as defective absorption, over production of CSF, brain atrophy, or obstruction of circulation. The additional CSF is stored in subarachnoid spaces of the brain or within the ventricles. This condition is also termed as hydrodynamic CSF disorder. Hydrocephalus majorly occurs in babies during birth. It also occurs in elderly people. If hydrocephalus happens in a newborn, it can physically deform the child as CSF continues to build up, causes the child’s head to expand to accommodate the excessive CSF. However, unlike an older child or adult, the infant head is able to expand since their fontanels are not yet closed. If hydrocephalus is left untreated, it can lead to mental retardation due to extreme pressure being exerted on surrounding cerebral tissue causing the brain to atrophy. Higher rates of neural tube defects and neonatal infection in emerging countries are related to advanced rates of hydrocephalus. Around 1% to 2% of the population of the U.S. was affected by hydrocephalus and over 350,000 procedures were performed to treat hydrocephalus in the country in 2014. Moreover, in Canada, one in every 1547 people suffers from hydrocephalus.

Based on type of product, the CSF management market has been classified into CSF shunts and CSF drainage systems. CSF drainage system has been further classified into ventricular drainage system and lumbar drainage system. The CSF shunts segment held the largest market share of the CSF management market in 2014. The segment is likely to continue to dominate the market during the forecast period. However, the CSF drainage systems segment is projected to expand at the highest growth rate during the forecast period. The overall rise in incidence of neurological diseases among the general population, increasing geriatric population diagnosed with neurological disease such as Alzheimer’s and Parkinson's diseases, high funding by the government and private organizations, and growing demand for minimally invasive surgeries are likely to drive the CSF management market. However, risk of infection during the time of surgery is expected to limit the usage of CSF shunts.

Geographically, the CSF management market has been segmented into North America, Europe, Asia-Pacific, Latin America, and Rest of the World. North America accounted for the largest share of the CSF management market in 2014. The region is likely to continue its dominance of the market during the forecast period due to increasing geriatric population and rapid technological innovations. However, the CSF management market in Asia-Pacific is anticipated to witness the fastest growth rate from 2015 to 2023 due to increasing demand for minimally invasive surgeries, rise in the geriatric population, and growing medical tourism in emerging nations. However, factors such as cost of surgical procedures and availability of shunts in developing countries can hinder the growth of the CSF management market.

Economic development and improving health care infrastructure in emerging economies such as China, India, and Brazil have led to increase in disposable income of people, thereby enhancing their purchasing power. In addition, increase in medical expenditure by governments creates an opportunity in the CSF management market in emerging countries.

Major players in the CSF Management Market consist of DePuy Synthes (a J & J Company), Medtronic plc, B. Braun Melsungen AG, Sophysa S.A., Spiegelberg GmbH & Co. KG, Integra LifeSciences Holding Corporation, BeckerSmith Medical, Inc., and Moller Medical GmbH.

csf-management-market

 

Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 CSF Management : Market Snapshot
2.2 Global CSF Management Market Share, by Geography, 2014 & 2023 (Value %)
2.3 Global CSF Management Market, by Product Type, 2014 (US$ Mn)

Chapter 3 Global CSF Management Market–Industry Analysis
3.1 Introduction
3.2 Market Dynamics
     3.2.1 Market Drivers
             3.2.1.1 Increase in the Global Geriatric Population
             3.2.1.2 Rise in acceptance of minimally invasive procedures
             3.2.1.3 
     3.2.2 Market Restraints
3.2.2.1 High cost of surgery
     3.2.3 Market Opportunities
             3.2.3.1 Increasing Awareness and Improving Health Care Infrastructure  in Emerging Economies Such as China, India, Brazil, and Russia
3.3 Porter’s Five Force Analysis of the Global CSF Management Market  
3.4 Market Attractiveness Analysis – CSF Management Market, by Geography, 2014
3.5 Competitive Landscape - Global CSF Management Market Share, by Key Players, 2014 (%)

Chapter 4 Global CSF Management Market, by Products
4.1 Global Cerebrospinal Fluid (CSF) Management Market Revenue, by Product, 2013–2023, (US$ Mn) and Analysis
4.2 Global CSF Shunts Market Revenue, 2013–2023, (US$ Mn) and Analysis
4.3 Global CSF Drainage Systems Market Revenue, by Product, 2013–2023, (US$ Mn) and Analysis
     4.3.1 Ventricular Drainage System and Analysis
     4.3.2. Lumbar Drainage System and Analysis

Chapter 5 Global CSF Management Market, by Geography
5.1 North America CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
     5.1.1 U.S. CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
     5.1.2 Canada CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.2 Europe CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
     5.2.1 U.K CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
     5.2.2 Germany CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
     5.2.3 France CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
     5.2.4 Rest of Europe CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.3 Asia Pacific CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
     5.3.1 China CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
     5.3.2 Japan CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
     5.3.3 Rest of Asia Pacific CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.4 Latin America CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
     5.4.1 Brazil CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
     5.4.2 Rest of Latin America CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.5 Rest of World CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
     5.5.1 South Africa CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis

Chapter 6  Recommendations
6.1 Future Trends: Invest in emerging markets such as China, Brazil, and India, among other
6.2 Barriers to Success

Chapter 7 Company Profiles
7.1 DePuy Synthes (a J & J Company)
     7.1.1 Company Overview
     7.1.2 Product Portfolio
     7.1.3 Financial Overview
     7.1.4 Recent Developments
7.2 Medtronic plc.
     7.2.1 Company Overview
     7.2.2 Product Portfolio
     7.2.3 Financial Overview
     7.2.4 Recent Developments
7.3 B.Braun Melsungen AG
     7.3.1 Company Profile
     7.3.2 Product Portfolio
     7.3.3 Financial Overview
     7.3.4 Recent Developments
7.4 Sophysa S.A. 
     7.4.1 Company Overview
     7.4.2 Product Portfolio
     7.4.3 Recent Developments 
7.5 Spiegelberg GmbH & Co. KG 
     7.5.1 Company Overview
     7.5.2 Product Portfolio
     7.5.3 Recent Developments
7.6 Integra LifeSciences Holding Corporation 
     7.6.1 Company Overview
     7.6.2 Product Portfolio
     7.6.3 Financial Overview
     7.6.4 Recent Developments
7.7 BeckerSmith Medical, Inc.
     7.7.1 Company Overview
     7.7.2 Product Portfolio
     7.7.3 Recent Developments
7.8 Moller Medical GmbH 
     7.8.1 Company Overview
     7.8.2 Product Portfolio
     7.8.3 Recent Developments

List of Figures 

FIG 1 Market Segmentation: Global CSF Management Market
FIG 2 Global CSF Management Market Share, by Geography, 2014 (%)
FIG 3 Global CSF Management Market Share, by Geography, 2023 (%)
FIG 4 Porter’s Five Forces Analysis
FIG 5 Market Attractiveness: Global CSF Management Market, by Geography, 2014 (Value %)
FIG 6 Competitive Landscape: Global CSF Management Market, by Key Players, 2014 (Value %)
FIG 7 Global CSF Shunts Market Revenue, 2013–2023, (US$ Mn)
FIG 8 Global Ventricular Drainage System Market Revenue, 2013–2023, (US$ Mn)
FIG 9 Global Lumbar Drainage System Market Revenue, 2013–2023, (US$ Mn)
FIG 10 North America CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 11 U.S CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 12 Canada CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 13 Europe CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 14 U.K. CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 15 Germany CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 16 France CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 17 Rest of Europe CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 18 Asia Pacific CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 19 China CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 20 Japan CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 21 Rest of Asia Pacific CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 22 Latin America CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 23 Brazil CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) 
FIG 24 Rest of Latin America CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 25 Rest of World CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) 
FIG 26 South Africa CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) 
FIG 27 Financial Overview: DePuy Synthes, 2012-2014 (US$ Mn)
FIG 28 Financial Overview: Medtronic plc. 2012-2014 (US$ Mn)
FIG 29 Financial Overview: B. Braun Melsungen AG, 2012-2014 (US$ Mn)
FIG 30 Financial Overview: Integra LifeSciences Holding Corporation, 2012-2014 (US$ Mn)

List of Tables 

Table 1: Global Cerebrospinal Fluid Management Market Snapshot
Table 2: Global Cerebrospinal Fluid (CSF) Management Market Revenue, by Product, 2013–2023, (US$  Mn)
Table 3: Global CSF Drainage Systems Market Revenue, by Product, 2013–2023, (US$ Mn)

Hydrocephalus is defined as an abnormal increase in the amount of cerebrospinal fluid inside the cranial cavity accompanied with enlargement of cerebral ventricles, which frequently leads to intracranial pressure and skull enlargement. Hydrocephalus majorly affects population aged 50 years and above. According to the World Population Prospects: the 2012 Revision (United Nations, Department of Economic and Social Affairs), the age group above 80 years, also referred as ‘oldest old’ in the report, was nearly 14% and is expected to increase to 19% by 2050. Earlier the treatment for hydrocephalus consisted of purging, bleeding, and puncturing of the ventricles to drain the fluid, surgical removal of fluid, application of cold wraps or plaster of herbs to the head, etc. There is no effective treatment for hydrocephalus. Diuretics such as Acetazolamide are medications prescribed to few hydrocephalus patients; however, these are temporary treatments. Hydrocephalus was considered a serious problem by neurosurgeons until the development of shunt valve. This transformed the quality of care for patients with hydrocephalus. 

This report on the global CSF management market analysis the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. This section also provides the overall information and data analysis of the global CSF management market with respect to the leading market segments based on type of product and geography. 

The market overview section of the report includes qualitative analysis of the CSF management market including the factors determining the market dynamics such as drivers, restraints, and opportunities along with Porter’s Five Forces Analysis. In addition, various analyses such as market attractiveness analysis by geography and competitive landscape by key players have been provided. The market attractiveness analysis explains the intensity of competition in the market in different regions. The competitive scenario between market players is evaluated through market share analysis. These factors would help market players to take strategic decisions in order to strengthen their positions and expand their share in the global market. 

The global CSF management market has been segmented based on type of product and geography. Based on type of product, the CSF management market has been categorized into two segments: CSF shunts and CSF drainage systems. CSF drainage system has been further classified into ventricular drainage system and lumbar drainage system. Market revenue in terms of US$ Mn for the period between 2013 and 2023 along with the compound annual growth rate (CAGR %) from 2015 to 2023 are provided for all the segments, considering 2014 as the base year. 

Geographically, the CSF management market has been categorized into five regions: North America, Europe, Asia Pacific, Latin America, and Rest of the World (RoW). North America comprises the U.S. and Canada. Europe includes Germany, the U.K., France, and Rest of Europe. Asia-Pacific comprises China, Japan, and Rest of Asia-Pacific. Latin America consists of Brazil and Rest of Latin America. Rest of the World includes South Africa and Rest of Rest of the World. The recommendations section included in the report would assist existing players to expand their market share and new companies to establish their presence in the CSF management market. The report also profiles major players in the CSF management market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include DePuy Synthes (a J & J Company), Medtronic plc, B. Braun Melsungen AG, Sophysa S.A., Spiegelberg GmbH & Co. KG, Integra LifeSciences Holding Corporation, BeckerSmith Medical, Inc., and Möller Medical GmbH. 

The global CSF management market has been segmented as follows:

Global CSF Management Market, by Product

  • CSF Shunts
  • CSF Drainage Systems
    • Ventricular Drainage System
    • Lumbar Drainage System

Global CSF Management Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific (APAC)
    • China
    • Japan
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of Latin America
  • Rest of the World
    • South Africa
    • Rest of Rest of the World


 
 
Back To Top